Bleeding prophylaxis in a child with cleft palate and factor VII deficiency: a case report. Pirrello R, Siragusa S, Giambona C, D'Arpa S, Cordova A, Moschella F. Source Dipartimento di Discipline Chirurgiche ed Oncologiche, Sezione di Chirurgia Plastica e Ricostruttiva, Università di Palermo, Palermo, Italy. Abstract The association between factor VII deficiency and cleft palate has never been described. The case of a child with cleft palate and factor VII deficiency who successfully underwent palatoplasty is described in this article. To allow surgical treatment, through maintenance of a normal prothrombin time, the patient was given 15 microg/kg of recombinant factor VIIa every 12 hours, starting 20 minutes before surgery and ending the third postoperative day. No abnormal perioperative bleeding was observed. Use of recombinant factor VIIa in bleeding prophylaxis or treatment is widespread. Doses are much higher in these cases. The reduction of dosage allows easier administration, especially in pediatric patients, without affecting drug efficacy

PIRRELLO R, SIRAGUSA S, GIAMBONA C, D'ARPA S, CORDOVA A, MOSCHELLA F (2006). Bleeding Prophylaxis in a Child With Cleft Palate and Factor VII Deficiency: A Case Report. CLEFT PALATE-CRANIOFACIAL JOURNAL, 43(1), 108-111 [10.1597/04-165.1].

Bleeding Prophylaxis in a Child With Cleft Palate and Factor VII Deficiency: A Case Report

PIRRELLO, Roberto;SIRAGUSA, Sergio;GIAMBONA, Cristiano;D'ARPA, Salvatore;CORDOVA, Adriana;MOSCHELLA, Francesco
2006-01-01

Abstract

Bleeding prophylaxis in a child with cleft palate and factor VII deficiency: a case report. Pirrello R, Siragusa S, Giambona C, D'Arpa S, Cordova A, Moschella F. Source Dipartimento di Discipline Chirurgiche ed Oncologiche, Sezione di Chirurgia Plastica e Ricostruttiva, Università di Palermo, Palermo, Italy. Abstract The association between factor VII deficiency and cleft palate has never been described. The case of a child with cleft palate and factor VII deficiency who successfully underwent palatoplasty is described in this article. To allow surgical treatment, through maintenance of a normal prothrombin time, the patient was given 15 microg/kg of recombinant factor VIIa every 12 hours, starting 20 minutes before surgery and ending the third postoperative day. No abnormal perioperative bleeding was observed. Use of recombinant factor VIIa in bleeding prophylaxis or treatment is widespread. Doses are much higher in these cases. The reduction of dosage allows easier administration, especially in pediatric patients, without affecting drug efficacy
2006
PIRRELLO R, SIRAGUSA S, GIAMBONA C, D'ARPA S, CORDOVA A, MOSCHELLA F (2006). Bleeding Prophylaxis in a Child With Cleft Palate and Factor VII Deficiency: A Case Report. CLEFT PALATE-CRANIOFACIAL JOURNAL, 43(1), 108-111 [10.1597/04-165.1].
File in questo prodotto:
File Dimensione Formato  
Fatt_VII.pdf

Solo gestori archvio

Descrizione: articolo principale
Dimensione 91.86 kB
Formato Adobe PDF
91.86 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/3407
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact